$BPMX Mr. Bosacki commented, "I'm excited about the potential of BioPharmX's proprietary HyantX delivery system and its underlying product candidates and I am thrilled to be working again with David." https://www.nasdaq.com/press-release/biopharmx-announces-steven-m-bosacki-joins-the-company-as-chief-operating-officer-20190716-00934